Osteoarthritis
“Turning responsibility on its head.” In a (to me) stunning 9-0 decision, The US Supreme Court awarded Merck and all drug manufacturers a huge gift. Rather than finding that Merck has the responsibility for ensuring that the medical community and patients are alerted to harms their drug can cause, the…
MedShadow Founder Su Robotti was in the courtroom for arguments in this important case and provides a first-hand account of the proceedings. On January 7, I sat in the chambers of the US Supreme Court to hear oral arguments from Merck, defending its actions — and inactions — as they…
If you suffer from knee osteoarthritis (OA) and think drugs can bring you pain relief over the long term, a new meta-analysis is challenging that assumption. Researchers examined trials that 47 that enrolled more than 22,000 people with knee OA who were given 31 different types of medication as treatment…
In a large-scale analysis of pain-relief medication for osteoarthritis, researchers found that paracetamol does not meet the minimum standard of clinical effectiveness in reducing pain or improving physical function in patients with knee and hip osteoarthritis. Although paracetamol was slightly better than placebo, researchers at the University of Bern conclude…
Patient Advocacy Site Offers 5 Questions for Doctors and 8 Lifestyle Changes to Increase Quality of Life NEW YORK CITY, NY, November 14, 2014 – Osteoarthritis (OA), the most common form of arthritis in the U.S., is a degenerative joint disease affecting more than 27 million men and women. Occurring…
